BackSecond Sight Medical Products Overview

Second Sight Medical Products Inventory

Latest inventory for EYES: $0.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00

Peer trimmed avg / median

Loading

Second Sight Medical Products Inventory History

Loading

Second Sight Medical Products vs. peers: Inventory Comparison

Loading

Second Sight Medical Products Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Second Sight Medical Products (EYES) FAQ

As of the most recent data (June 2026), EYES shows a inventory of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EYES's inventory is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Second Sight Medical Products is outperforming or lagging.

Tracking EYES's inventory over time shows whether Second Sight Medical Products is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Second Sight Medical Products's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $0) with ownership activity and broader fundamentals.

Second Sight Medical Products's inventory is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.